Fig. 2From: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PETRepresentative example of imaging modalities MRI T1, T2*, and FMISO-PET. Primary tumour and lymph node metastasis (pt. 5, tonsillar carcinoma) at week 0, 2, and 5 (upper, middle, lower panel): co-registered image sets from MRI T1, MRI T2*, FMISO-PET (left to right). Red contours: GTV-T, GTV-LN. Blue contour: HSV-LNBack to article page